Tohru Yamada

Oak Park, IL, United States of America

Tohru Yamada

USPTO Granted Patents = 35 

 

Average Co-Inventor Count = 5.0

ph-index = 8

Forward Citations = 200(Granted Patents)


Location History:

  • Lombard, IL (US) (2012 - 2020)
  • Oak Park, IL (US) (2007 - 2021)

Company Filing History:


Years Active: 2007-2021

Loading Chart...
Loading Chart...
35 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Tohru Yamada

Introduction

Tohru Yamada is a prominent inventor based in Oak Park, IL, with an impressive portfolio of 35 patents. His innovative work primarily focuses on the development of novel compositions and methods aimed at treating conditions related to ephrin signaling, particularly in cancer therapy.

Latest Patents

Among his latest patents, Tohru’s groundbreaking invention titled "Compositions and methods for treating conditions related to ephrin signaling with Cupredoxins" stands out. This invention delves into the use of cupredoxins, their derivatives, and structural equivalents to disrupt the ephrin signaling system in mammalian cells, ultimately targeting cancer treatment. Another significant patent, "Compositions comprising cupredoxins for treating cancer," reveals methodologies for killing and inhibiting the growth of cancer cells through the preferential entry of cytotoxic compounds. This is achieved by employing protein transduction domains derived from cupredoxins, such as the p18 and p28 truncations of azurin.

Career Highlights

Tohru Yamada has had a fruitful career with notable contributions to the field of biomedical innovation. He has been affiliated with the University of Illinois, where his research and inventions have garnered recognition and have had a substantial impact on cancer treatment methodologies.

Collaborations

Throughout his career, Tohru has collaborated with esteemed colleagues such as Tapas Das Gupta and Ananda M Chakrabarty. These partnerships have complemented his research efforts and further enhanced the development of innovative therapeutic solutions.

Conclusion

Tohru Yamada's commitment to innovation is evident in his extensive patent portfolio and his collaborative efforts with leading experts in the field. His unique approaches to treating cancer through novel applications of cupredoxins mark him as a significant figure in the realm of biomedical innovation and research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…